WHY IT MATTERS: If you are a medical cannabis patient who drives, understanding the specific timing and formulation of your medication is critical to both your legal safety and your actual ability to operate a vehicle without impairment. CLINICAL OVERVIEW: Research examining driving behaviors among medical cannabis patients raises important questions about how THC affects psychomotor function, reaction time, and judgment at various doses and time points after consumption. The relationship between measured THC levels and actual impairment is complex, as tolerance, route of administration, and individual pharmacokinetics all influence functional capacity behind the wheel.
A new way to study how cannabis use impacts safe driving | EurekAlert!
WHY IT MATTERS: If you use cannabis medicinally and drive, better research into impairment testing could eventually replace unreliable THC blood level thresholds with assessments that more fairly and accurately reflect whether you are actually safe behind the wheel. CLINICAL OVERVIEW: As cannabis legalization continues to expand across the United States, research into how cannabis use affects driving performance remains critically underdeveloped, creating a significant gap between policy and patient safety evidence. New approaches to studying cannabis-impaired driving are essential because unlike alcohol, THC affects psychomotor function in highly variable ways depending on tolerance, dosing method, cannabinoid profile, and individual metabolism.